logo

This website uses cookies to ensure you get the best experience on our website.

Read through our Privacy Policy to learn more.

 Go Back

Sangamo: Q2 Earnings Snapshot

By AP News - Aug 06, 2024, 04:38 PM ET
Last Updated - Aug 06, 2024, 04:38 PM EDT
Sangamo: Q2 Earnings Snapshot

RICHMOND, Calif. (AP) — RICHMOND, Calif. (AP) — Sangamo Therapeutics Inc. (SGMO) on Tuesday reported a loss of $36.1 million in its second quarter.

The Richmond, California-based company said it had a loss of 18 cents per share. Losses, adjusted for asset impairment costs, came to 17 cents per share.

Sponsored

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The drug developer posted revenue of $356,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGMO at https://www.zacks.com/ap/SGMO

Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250415